0.7914

1.08% -0.0086

After Hours: .81 0.0186 +2.35%

Vor Biopharma Inc (VOR)

Overview News Price History Option Chain Financials Discussions Forecast

Vor Biopharma Inc stock is traded at $0.7914, with a volume of 341.23K. It is down -1.08% in the last 24 hours and up +8.89% over the past month. Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.

Previous Close:

$0.80

Open:

$0.8005

24h Volume:

341.23K

Relative Volume:

0.36

Market Cap:

$54.43M

Revenue:

Net Income/Loss:

$-115.51M

P/E Ratio:

-0.3899

EPS:

-2.03

Net Cash Flow:

$-95.89M

1W Performance:

-0.43%

1M Performance:

+8.89%

6M Performance:

-49.11%

1Y Performance:

-57.90%

1-Day Range:

$0.7601

$0.8151

1-Week Range:

$0.7537

$0.8559

52-Week Range:

$0.63

$3.1399

Vor Biopharma Inc Stock (VOR) Company Profile

Name

Vor Biopharma Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

617-655-6580

Address

100 CAMBRIDGEPARK DRIVE, CAMBRIDGE

Employee

168

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

VOR's Discussions on Twitter

Compare VOR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VOR Vor Biopharma Inc	0.7914	54.43M	0	-115.51M	-95.89M	-2.03
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-26-22	Initiated	Wedbush	Outperform
Apr-27-22	Initiated	Goldman	Neutral
Dec-17-21	Initiated	H.C. Wainwright	Buy
Dec-03-21	Initiated	Robert W. Baird	Outperform
Dec-02-21	Initiated	Oppenheimer	Outperform
Oct-19-21	Initiated	JMP Securities	Mkt Outperform
Mar-25-21	Initiated	B. Riley Securities	Buy
Mar-03-21	Initiated	Barclays	Overweight
Mar-03-21	Initiated	Evercore ISI	Outperform
Mar-02-21	Initiated	Goldman	Sell
Mar-02-21	Initiated	Stifel	Buy

View All

Vor Biopharma Inc Stock (VOR) Latest News

Nov 22, 2024

Vor Biopharma Inc. (NYSE:VOR) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Nov 22, 2024

Navigator Holdings Ltd. (NYSE:NVGS) Given Consensus Rating of “Buy” by Brokerages - Defense World

Nov 22, 2024

Astrana Health, Inc. (NASDAQ:ASTH) Receives Consensus Rating of “Buy” from Analysts - Defense World

Nov 22, 2024

Vor Biopharma Inc. (NYSE:VOR) Given Consensus Rating of “Buy” by Analysts - Defense World

Nov 22, 2024

Kosmos Energy Ltd. (NYSE:KOS) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Nov 22, 2024

Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Nov 22, 2024

Nov 14, 2024

VOR Biopharma's SWOT analysis: stock shows promise amid clinical progress - Investing.com Nigeria

Nov 14, 2024

Nov 12, 2024

Vor Bio to Participate in the Stifel 2024 Healthcare Conference - GlobeNewswire

Nov 12, 2024

Vor Bio to Present at Stifel Healthcare Conference, Host Key Investor Meetings | VOR Stock News - StockTitan

Nov 12, 2024

Robert W. Baird Lowers Vor Biopharma (NYSE:VOR) Price Target to $14.00 - Defense World

Nov 12, 2024

Vor Biopharma (NYSE:VOR) Price Target Lowered to $14.00 at Robert W. Baird - MarketBeat

Nov 08, 2024

Vor Biopharma Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024

Nov 07, 2024

Vor Biopharma : Bio Corporate Presentation November 2024 - Marketscreener.com

Nov 07, 2024